The addition of sintilimab to neoadjuvant chemoradiotherapy achieved a 60% pathological complete response rate vs 47.3% with ...

The findings suggest that "supportive care and management of geriatric vulnerabilities at baseline may improve outcomes and ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

The first week of President Donald Trump’s second term included several executive orders and actions that will be detrimental ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its Welireg oral cancer drug in patients with rare tumors that form in and around the ...

In a report released on January 24, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research ...

Robert F. Kennedy Jr. is set to appear before the Senate Finance Committee for the first of two confirmation hearings as ...

Robert F. Kennedy Jr. plans to continue earning from legal cases while heading the Department of Health and Human Services, ...

Merck expands operations to position itself as a critical manufacturing hub in the APAC region: Our Bureau, Bengaluru Monday, January 27, 2025, 10:45 Hrs [IST] Merck has announced ...

The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...

Twenty individuals from across Kansas have been named to the 2025 KLA Young Stockmen’s Academy (YSA). The class will spend ...

Chinese regulators are investigating the quality of domestic generic drugs after a rare public backlash against a cost-cutting campaign that prioritised their use in the national healthcare system but ...